Chronic Liver Disease is a progressive situation where long-term damage (from alcohol, viruses, or fat) leads to liver scarring (fibrosis), cirrhosis, and eventual organ failure. At Liver Surgeons, Delhi’s premier CLD treatment center, we focus on slowing disease progression, managing complications, and improving quality of life.
Life-saving dual organ transplantation with 80% 5-year survival rates
Early detection saves lives. Watch for:
CT Angiography: Maps blood flow abnormalities.
Mr. Sharma’s Journey
“Alcohol damaged my liver, but Dr. Ashish George’s team in Delhi reversed my fibrosis with medication and counseling. I’m sober and healthier today!”
Ms. Kapoor’s Journey
“Hepatitis C scarred my liver, but Dr. Ashish George’s team in Delhi cured it with advanced antivirals. Today, I’m virus-free and full of energy!”
Early-stage fibrosis (F0-F2) can regress with alcohol cessation, weight loss, or antivirals. Cirrhosis (F4) is irreversible but manageable with proper medical care.
NAFLD stems from metabolic issues (obesity/diabetes); ALD from alcohol. Both cause fibrosis, but treatment differs – NAFLD needs lifestyle changes, while ALD requires complete abstinence.
Medications start at ₹5,000/month, while transplants can cost up to ₹35 lakhs. We provide EMI options and assist with insurance claims for comprehensive care.
We use beta-blockers, endoscopic variceal ligation, or TIPS procedures to reduce vein pressure and prevent life-threatening bleeding complications.
For end-stage liver disease with complications like ascites, hepatic encephalopathy, or when MELD score reaches ≥15. Our transplant team evaluates each case individually.
Key recommendations include:
• Low sodium to reduce fluid retention
• High-quality plant-based proteins
• Complete alcohol avoidance
• Calorie control for NAFLD patients
Our nutritionists create personalized meal plans for liver repair.
Testing frequency depends on disease stage:
• Early CLD: Every 6 months
• Advanced cirrhosis: Every 3 months
We customize schedules based on your fibrosis stage and portal hypertension risks.
No. We primarily use non-invasive tools like FibroScan® and MRI elastography for staging. Biopsies are reserved for complex cases where imaging results are inconclusive.